LENZ has announced an exclusive licensing and commercialisation agreement with Lotus Pharmaceutical of Taiwan.

The executive order aims to cut US prescription drug costs by linking them to the lowest prices paid internationally.

Both the FDA and EMA have suspended Ixchiq’s use in older adults after post-marketing serious adverse events that include two ...

Isolator lines present several significant advantages for large-scale aseptic filling, as Marcel Langner of IDT Biologika ...

Eli Lilly and Purdue University, US, have announced the widening of their existing partnership with a planned investment of ...

AAN conference featured the latest research and developments in neurological disorders like Alzheimer's disease, epilepsy and ...